GlaxoSmithKline
- Country
- π¬π§United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV
- Conditions
- Interventions
- Biological: RSV (GSK3389245A) lower dose formulation vaccineBiological: RSV (GSK3389245A) higher dose formulation vaccineBiological: GSK's multicomponent meningococcal B vaccineBiological: Pfizer's meningococcal group A, C, W-135 and Y conjugate vaccineBiological: GSK's pneumococcal polysaccharide conjugate vaccineBiological: GSK's meningococcal group A, C, W-135 and Y conjugate vaccineDrug: Placebo
- First Posted Date
- 2018-08-17
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 201
- Registration Number
- NCT03636906
- Locations
- π¬π§
GSK Investigational Site, Southampton, United Kingdom
Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study
- Conditions
- Interventions
- First Posted Date
- 2018-08-14
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 6051
- Registration Number
- NCT03629886
- Locations
- π¨π³
GSK Investigational Site, Yancheng, Jiangsu, China
First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of GSK3439171A in Healthy Subjects and to Assess Food Effect
- First Posted Date
- 2018-08-13
- Last Posted Date
- 2020-07-10
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 66
- Registration Number
- NCT03627494
- Locations
- πΊπΈ
GSK Investigational Site, Baltimore, Maryland, United States
Twinrix Pregnancy Registry
- First Posted Date
- 2018-08-08
- Last Posted Date
- 2019-02-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 245
- Registration Number
- NCT03619590
Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants
- Conditions
- Interventions
- First Posted Date
- 2018-08-08
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1200
- Registration Number
- NCT03621670
- Locations
- π΅π·
GSK Investigational Site, San Juan, Puerto Rico
Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
- First Posted Date
- 2018-08-03
- Last Posted Date
- 2023-02-06
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 30
- Registration Number
- NCT03614728
- Locations
- π¨π¦
GSK Investigational Site, Toronto, Ontario, Canada
A Study of Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance
- First Posted Date
- 2018-08-03
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 4493
- Registration Number
- NCT03614676
- Locations
- πΉπ
GSK Investigational Site, Chiang Mai, Thailand
Post-marketing Surveillance (PMS) Study to Observe the Safety and Effectiveness of ARNUITY in Asthma Subjects in a Real World Setting
- First Posted Date
- 2018-07-23
- Last Posted Date
- 2020-08-24
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 668
- Registration Number
- NCT03595930
- Locations
- π°π·
GSK Investigational Site, Seoul, Korea, Republic of
Phase I Study of GSK2982772 in Japanese Healthy Male Participants
- First Posted Date
- 2018-07-18
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 13
- Registration Number
- NCT03590613
- Locations
- π―π΅
GSK Investigational Site, Fukuoka, Japan
Effect of Two Toothpastes on Bacteria in Saliva
- Conditions
- Interventions
- First Posted Date
- 2018-07-16
- Last Posted Date
- 2019-07-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 15
- Registration Number
- NCT03587428
- Locations
- π¬π§
GSK Investigational Site, Weybridge, United Kingdom